We are live on ! Find out more
RIM

RS Investment Management Portfolio holdings

AUM $9.73B
1-Year Est. Return 3.24%
This Fund
S&P 500
This Quarter Est. Return
+3.32%
1 Year Est. Return
+3.24%
3 Year Est. Return
+50.37%
5 Year Est. Return
10 Year Est. Return
AUM
$11.7B
AUM Growth
+$454M
Cap. Flow
+$270M
Cap. Flow %
2.32%
Top 10 Hldgs %
11.73%
Holding
405
New
54
Increased
162
Reduced
112
Closed
55

Sector Composition

Rank Sector Weight
1 Healthcare 17.28%
2 Consumer Discretionary 16.89%
3 Financials 16.56%
4 Technology 14.66%
5 Industrials 10.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KEY icon
226
KeyCorp
KEY
$23.2B
$13.4M 0.11%
891,638
-76,910
-8% -$1.13M
NXPI icon
227
NXP Semiconductors
NXPI
$57.1B
$13.1M 0.11%
133,412
+5,263
+4% +$540K
BPMC
228
DELISTED
Blueprint Medicines
BPMC
$13M 0.11%
+492,510
New +$14.1M
CBL
229
DELISTED
CBL& Associates Properties, Inc.
CBL
$13M 0.11%
801,158
-713,270
-47% -$12.9M
RDC
230
DELISTED
Rowan Companies Plc
RDC
$12.9M 0.11%
612,739
-24,983
-4% -$529K
ILMN icon
231
Illumina
ILMN
$33.6B
$12.8M 0.11%
60,220
-1,902
-3% -$371K
CSTE icon
232
Caesarstone
CSTE
$104M
$12.8M 0.11%
+186,190
New +$11.5M
AMZN icon
233
Amazon
AMZN
$2.68T
$12.4M 0.11%
572,400
+237,600
+71% +$4.97M
CYAD
234
DELISTED
Celyad Oncology SA American Depositary Shares
CYAD
$12.4M 0.11%
+238,330
New +$12.8M
ATYR
235
aTyr Pharma
ATYR
$38.2M
$12.4M 0.11%
+47,803
New +$14.8M
DLTR icon
236
Dollar Tree
DLTR
$21.2B
$12.3M 0.11%
155,871
+60,579
+64% +$4.79M
CELG
237
DELISTED
Celgene Corp
CELG
$12.3M 0.11%
106,224
+8,855
+9% +$1.01M
BIIB icon
238
Biogen
BIIB
$31.9B
$11.9M 0.1%
29,507
+2,310
+8% +$927K
ULTA icon
239
Ulta Beauty
ULTA
$23.3B
$11.8M 0.1%
76,117
+4,275
+6% +$657K
ABUS icon
240
Arbutus Biopharma
ABUS
$1B
$11.5M 0.1%
972,540
+396,400
+69% +$6.03M
LRCX icon
241
Lam Research
LRCX
$339B
$11.5M 0.1%
1,415,350
+341,210
+32% +$2.68M
PMT
242
PennyMac Mortgage Investment
PMT
$783M
$11.5M 0.1%
658,236
+23,180
+4% +$451K
AIG icon
243
American International
AIG
$39.7B
$11.4M 0.1%
+184,350
New +$10.9M
COL
244
DELISTED
Rockwell Collins
COL
$11M 0.09%
+118,940
New +$11.4M
RKT
245
DELISTED
ROCK-TENN COMPANY CL-A
RKT
$10.8M 0.09%
179,371
+683
+0.4% +$43.2K
HLT icon
246
Hilton Worldwide
HLT
$69.3B
$10.7M 0.09%
129,445
-5,958
-4% -$523K
MDCO
247
DELISTED
Medicines Co
MDCO
$10.5M 0.09%
367,318
+28,960
+9% +$807K
LULU icon
248
lululemon athletica
LULU
$10.9B
$10.1M 0.09%
154,790
+20,090
+15% +$1.31M
KR icon
249
Kroger
KR
$37.1B
$10.1M 0.09%
277,738
-57,640
-17% -$2.1M
AKAM icon
250
Akamai
AKAM
$15.1B
$9.96M 0.09%
142,630
+17,310
+14% +$1.28M

Similar funds

RS Investment Management's Q2 2015 Portfolio in Review

As of Q2 2015, RS Investment Management held 405 positions worth $11.7B, up 4% from $11.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

RS Investment Management's Q2 2015 filing shows 54 new, 162 increased, 112 reduced and 55 closed positions. Its largest new stake was Repligen: 1,382,573 shares worth $57.1M. The largest sale was INFORMATICA CORP, an estimated $78.4M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.

  • RS Investment Management's largest Q2 2015 buy was Repligen: 1,382,573 shares worth $57.1M.
  • RS Investment Management added most to Equity Commonwealth in Q2 2015, an estimated $59.8M increase.
  • RS Investment Management's biggest Q2 2015 reduction was ROSETTA RESOURCES INC, cutting an estimated $46.1M.
  • RS Investment Management fully exited INFORMATICA CORP in Q2 2015, selling an estimated $78.4M.
  • RS Investment Management's ten largest holdings make up 12% of its $11.7B portfolio in Q2 2015.
  • RS Investment Management opened 54 new positions and closed 55 in Q2 2015.
  • RS Investment Management's portfolio value rose 4% quarter-over-quarter to $11.7B.

Based on RS Investment Management's 13F filing for Q2 2015, filed 13 Aug 2015.